1. Home
  2. QLGN vs FRGT Comparison

QLGN vs FRGT Comparison

Compare QLGN & FRGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QLGN
  • FRGT
  • Stock Information
  • Founded
  • QLGN 1996
  • FRGT 2015
  • Country
  • QLGN United States
  • FRGT United States
  • Employees
  • QLGN N/A
  • FRGT N/A
  • Industry
  • QLGN Biotechnology: Pharmaceutical Preparations
  • FRGT Professional Services
  • Sector
  • QLGN Health Care
  • FRGT Consumer Discretionary
  • Exchange
  • QLGN Nasdaq
  • FRGT Nasdaq
  • Market Cap
  • QLGN 3.2M
  • FRGT 2.9M
  • IPO Year
  • QLGN N/A
  • FRGT N/A
  • Fundamental
  • Price
  • QLGN $4.07
  • FRGT $1.36
  • Analyst Decision
  • QLGN
  • FRGT
  • Analyst Count
  • QLGN 0
  • FRGT 0
  • Target Price
  • QLGN N/A
  • FRGT N/A
  • AVG Volume (30 Days)
  • QLGN 20.7K
  • FRGT 204.8K
  • Earning Date
  • QLGN 11-14-2024
  • FRGT 01-28-2025
  • Dividend Yield
  • QLGN N/A
  • FRGT N/A
  • EPS Growth
  • QLGN N/A
  • FRGT N/A
  • EPS
  • QLGN N/A
  • FRGT N/A
  • Revenue
  • QLGN N/A
  • FRGT $17,567,033.00
  • Revenue This Year
  • QLGN N/A
  • FRGT $144.53
  • Revenue Next Year
  • QLGN N/A
  • FRGT $55.01
  • P/E Ratio
  • QLGN N/A
  • FRGT N/A
  • Revenue Growth
  • QLGN N/A
  • FRGT N/A
  • 52 Week Low
  • QLGN $3.34
  • FRGT $1.25
  • 52 Week High
  • QLGN $29.45
  • FRGT $80.75
  • Technical
  • Relative Strength Index (RSI)
  • QLGN 45.00
  • FRGT 38.55
  • Support Level
  • QLGN $3.95
  • FRGT $1.25
  • Resistance Level
  • QLGN $4.21
  • FRGT $1.47
  • Average True Range (ATR)
  • QLGN 0.27
  • FRGT 0.20
  • MACD
  • QLGN 0.00
  • FRGT -0.07
  • Stochastic Oscillator
  • QLGN 22.08
  • FRGT 10.09

About QLGN Qualigen Therapeutics Inc.

Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.

About FRGT Freight Technologies Inc.

Freight Technologies Inc is a technology company developing solutions to optimize and automate the supply chain process. Along with its subsidiary, Freight App, Inc, the group is focused on making shipping transparent and efficient. Fr8App provides carriers with increased growth opportunities and shippers with flexibility, visibility, and simplicity for the once-complex process of international over-the-road (OTR) shipping. The company uses its proprietary technology platform to connect carriers and shippers and significantly improve matching and operation efficiency via technologies such as live pricing and real-time tracking, digital freight marketplace, broker, transportation management, fleet management, and committed capacity solutions.

Share on Social Networks: